Immune Features of Ovarian Tumors with a Good Response to Neo-Adjuvant Chemotherapy in Combination with an Anti-Pd-l1 Alone or with an Anti-Ctla4: Data from the Randomized IneOV Trial (a GINECO Study)
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined